Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Feb;14(1):25-33.
doi: 10.1007/s10238-012-0213-6. Epub 2012 Sep 27.

Regulatory considerations in production of a cell therapy medicinal product in Europe to clinical research

Affiliations
Review

Regulatory considerations in production of a cell therapy medicinal product in Europe to clinical research

Patricia Gálvez Martín et al. Clin Exp Med. 2014 Feb.

Abstract

The development of new drugs using stem cells has become a clinic alternative for the treatment of different diseases such as Alzheimer's, diabetes and myocardial infarction. Similar to conventional medicines, stem cells as new medicinal products for cell therapy are subjected to current legislation concerning their manufacture process. Besides, their legality is determined by the Regulatory Agencies belonging to the Member State of the European Union in which they are being registered. With the evolution of therapy that uses cells as medicines, there is a need to develop the appropriate legislative and regulatory framework capable of ensuring their safety and effectiveness. However, few works have been published regarding the regulations that these products must comply through production and commercialization processes. The present work is focused on the description of key events during clinical development and cell production of stem cells as drugs. Such as the regulations, requirements and directives involved in the production of cell therapy medicinal products, from the clinical design stage to its commercialization in Europe.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Curr Top Dev Biol. 2012;100:319-44 - PubMed
    1. Transfusion. 2005 Oct;45(4 Suppl):144S-58S - PubMed
    1. J Transl Med. 2009 Sep 08;7:78 - PubMed
    1. Hematology Am Soc Hematol Educ Program. 2002;:369-91 - PubMed
    1. Regen Med. 2010 Nov;5(6):971-85 - PubMed

LinkOut - more resources